

Bringing data science and human science together to advance human health and support the pharmaceutical industry from clinical trials to commercialization.
Learn More
Connecting with powerful, evidence-based market insights to drive agile thinking, uncover growth potential, and gain competitive advantage in this fast-moving consumer health market.
LEARN MORE
Empowering to orchestrate operations across the entire product lifecycle, from concept-to-market, providing quality control, regulatory, safety and compliance solutions along the way.
Learn more
Working across the health system to address key barriers to deliver high-quality, cost-effective care while improving health outcomes using our data-driven and population-centric solutions.
LEARN MORE
Delivering a wide range of consulting and technology solutions to support healthcare stakeholders to drive operational efficiency, enhance quality of patient care, and improve systemic outcomes.
learn more
Clinical development enabled by Connected Intelligence™ which combines data and analytics with deep therapeutic and operational expertise to improve efficiency, enhance precision, and bring therapies to patients faster.
Learn More
Harness the power of real-world data and insights to demonstrate value-driven evidence and outcomes to meet stakeholder needs across the healthcare ecosystem and to propel healthcare forward.
LEARN MORE
Pharmaceutical market data and information assets that provide actionable data points to help organizations make intelligent connections and drive healthcare forward.
LEARN MORE
Primary Intelligence integrates purpose-built and syndicated research solutions with our wide range of data assets, research methodologies, advanced analytics, and deep domain expertise, generating quality insights for our clients.
LEARN MORE
Trusted advisor and partner to global healthcare organisations, solving the most significant business challenges through extensive healthcare expertise.
LEARN MORE
Optimize commercial success by leveraging our comprehensive outsourced expertise to accelerate time-to-market.
LEARN MORE
A single window solution provider to support pharmaco’s design, deploy technology and services that help increase access to medicine and improve treatment adherence.
LEARN MORE
Connected Intelligence™, digital insights, data analytics and advanced technology to power smarter decision-making to enable better patient outcomes and improved business results.
LEARN MOREGet the latest insights on our life sciences, healthcare, and medical technology solutions in Asia Pacific.
Learn MoreExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
Discover Insights
"Unlocking Pharmaceutical Potential: The Growing Role of Thai Clinics
Read moreImproving human health needs innovative thinkers. Unleash your potential with us.
Search JobsDiscover how industry experts recognize IQVIA's impact across the Asia Pacific region.
LEARN MORE
May 12, 2020
Calendar
9:00am - 10:00am
(GMT+08:00)
The MedTech industry faces a rapidly changing healthcare ecosystem across the entire Asia Pacific region. This flux has ignited interest in different methods of assessing medical technologies to inform value-based decision-making, one of which is Health Technology Assessment.
In partnership with APACMed, IQVIA MedTech has recently launched a new white paper: The Evolving Health Technology Assessment for Medical Devices and Diagnostics in the Asia Pacific Region and Key Considerations for Value Assessment Frameworks.
This authoritative report addresses the different levels of understanding around which, when and how medical technologies should be evaluated and is ideal for agencies looking to grow their knowledge base in policy and reimbursement decision making.
Join us for an exclusive webinar on Tuesday, 12 May 2020, where we will hear from IQVIA Asia Pacific's Sirinthip Petcharapiruch and Boston Scientific's Virginia Priest as they share key takeaways from the paper and crucially discuss objectives and opportunities to collaboratively support value-driven medical technology assessments going forward.